164 related articles for article (PubMed ID: 34381069)
1. k-core genes underpin structural features of breast cancer.
Dorantes-Gilardi R; García-Cortés D; Hernández-Lemus E; Espinal-Enríquez J
Sci Rep; 2021 Aug; 11(1):16284. PubMed ID: 34381069
[TBL] [Abstract][Full Text] [Related]
2. The Role of Transcription Factors in the Loss of Inter-Chromosomal Co-Expression for Breast Cancer Subtypes.
Trujillo-Ortíz R; Espinal-Enríquez J; Hernández-Lemus E
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139393
[TBL] [Abstract][Full Text] [Related]
3. Luminal A Breast Cancer Co-expression Network: Structural and Functional Alterations.
García-Cortés D; Hernández-Lemus E; Espinal-Enríquez J
Front Genet; 2021; 12():629475. PubMed ID: 33959148
[TBL] [Abstract][Full Text] [Related]
4. Loss of Long Distance Co-Expression in Lung Cancer.
Andonegui-Elguera SD; Zamora-Fuentes JM; Espinal-Enríquez J; Hernández-Lemus E
Front Genet; 2021; 12():625741. PubMed ID: 33777098
[TBL] [Abstract][Full Text] [Related]
5. A mixture model to detect edges in sparse co-expression graphs with an application for comparing breast cancer subtypes.
Bar H; Bang S
PLoS One; 2021; 16(2):e0246945. PubMed ID: 33571253
[TBL] [Abstract][Full Text] [Related]
6. Prognosis related genes in HER2+ breast cancer based on weighted gene co-expression network analysis.
Weng Y; Jia R; Li Z; Liang W; Ji Y; Liang Y; Ning P
Chin Med J (Engl); 2023 May; 136(10):1258-1260. PubMed ID: 37104618
[No Abstract] [Full Text] [Related]
7. A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes.
Dutta B; Pusztai L; Qi Y; André F; Lazar V; Bianchini G; Ueno N; Agarwal R; Wang B; Shiang CY; Hortobagyi GN; Mills GB; Symmans WF; Balázsi G
Br J Cancer; 2012 Mar; 106(6):1107-16. PubMed ID: 22343619
[TBL] [Abstract][Full Text] [Related]
8. The Performance Comparison of Gene Co-expression Networks of Breast and Prostate Cancer using Different Selection Criteria.
Cingiz MÖ; Biricik G; Diri B
Interdiscip Sci; 2021 Sep; 13(3):500-510. PubMed ID: 34003445
[TBL] [Abstract][Full Text] [Related]
9. The dual role of FOXF2 in regulation of DNA replication and the epithelial-mesenchymal transition in breast cancer progression.
Lo PK; Lee JS; Liang X; Sukumar S
Cell Signal; 2016 Oct; 28(10):1502-19. PubMed ID: 27377963
[TBL] [Abstract][Full Text] [Related]
10. Development of a 15-Gene Signature Model as a Prognostic Tool in Sex Hormone-Dependent Cancers.
Xia Z; Xiao J; Liu A; Chen Q
Biomed Res Int; 2021; 2021():3676107. PubMed ID: 34869761
[TBL] [Abstract][Full Text] [Related]
11. Revealing nuclear receptor hub modules from Basal-like breast cancer expression networks.
Hsu SN; Hui EWE; Liu M; Wu D; Hughes TA; Smith J
PLoS One; 2021; 16(6):e0252901. PubMed ID: 34161324
[TBL] [Abstract][Full Text] [Related]
12. The gene expression landscape of breast cancer is shaped by tumor protein p53 status and epithelial-mesenchymal transition.
Fredlund E; Staaf J; Rantala JK; Kallioniemi O; Borg A; Ringnér M
Breast Cancer Res; 2012 Jul; 14(4):R113. PubMed ID: 22839103
[TBL] [Abstract][Full Text] [Related]
13. Network-based approach to identify prognostic biomarkers for estrogen receptor-positive breast cancer treatment with tamoxifen.
Liu R; Guo CX; Zhou HH
Cancer Biol Ther; 2015; 16(2):317-24. PubMed ID: 25756514
[TBL] [Abstract][Full Text] [Related]
14. Identification of the key pathways and genes involved in HER2-positive breast cancer with brain metastasis.
Lu X; Gao C; Liu C; Zhuang J; Su P; Li H; Wang X; Sun C
Pathol Res Pract; 2019 Aug; 215(8):152475. PubMed ID: 31178227
[TBL] [Abstract][Full Text] [Related]
15. Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer.
Cejalvo JM; Martínez de Dueñas E; Galván P; García-Recio S; Burgués Gasión O; Paré L; Antolín S; Martinello R; Blancas I; Adamo B; Guerrero-Zotano Á; Muñoz M; Nucíforo P; Vidal M; Pérez RM; Chacón López-Muniz JI; Caballero R; Peg V; Carrasco E; Rojo F; Perou CM; Cortés J; Adamo V; Albanell J; Gomis RR; Lluch A; Prat A
Cancer Res; 2017 May; 77(9):2213-2221. PubMed ID: 28249905
[TBL] [Abstract][Full Text] [Related]
16. Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypes.
Gatza ML; Kung HN; Blackwell KL; Dewhirst MW; Marks JR; Chi JT
Breast Cancer Res; 2011 Jun; 13(3):R62. PubMed ID: 21672245
[TBL] [Abstract][Full Text] [Related]
17. Identification of key candidate genes, pathways and related prognostic values in ER-negative/HER2-negative breast cancer by bioinformatics analysis.
Shao N; Yuan K; Zhang Y; Yun Cheang T; Li J; Lin Y
J BUON; 2018; 23(4):891-901. PubMed ID: 30358191
[TBL] [Abstract][Full Text] [Related]
18. Comparative Analysis of Gene Correlation Networks of Breast Cancer Patients Based on Mutations in TP53.
Park B; Im J; Han K
Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883535
[TBL] [Abstract][Full Text] [Related]
19. A global [Formula: see text] gene co-expression network constructed from hundreds of experimental conditions with missing values.
Kuang J; Buchon N; Michel K; Scoglio C
BMC Bioinformatics; 2022 May; 23(1):170. PubMed ID: 35534830
[TBL] [Abstract][Full Text] [Related]
20. Screening and Bioinformatics Analysis of Competitive Endogenous RNA Regulatory Network --Related to Circular RNA in Breast Cancer.
Wang T; Zhang Y; He Y; Liu Y; Qi P
Biomed Res Int; 2021; 2021():5575286. PubMed ID: 34545330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
